SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Radar · where your analysis starts

Find what deserves
a closer look.

Every morning, Radar runs the companies we cover through the lens you choose and leaves a short list. Each candidate comes with why it appears, what calls for caution and the notices from its record. Below, a real list from Aug 11, 2026.

  • US and Europe
  • Beta by invitation
  • Triage with judgment

Not advice: it organizes evidence and priority. The decision is yours.

Each point is a real company we cover: 7,242 across 11 exchanges.

Real candidate · Core list of Aug 11, 2026

Globus Medical Inc.GMED

Repricing in motion and Growth support. Priority 73.4 out of 100 that day.

Liquidity, coverage and lens: of the 100 that passed Core on Aug 11, 2026 we show 8.

  • A short list with reasons
  • What calls for caution, in plain sight
  • A path to the evidence

Start with a question

Choose a lens. See what changes.

A lens is a screening criterion: what it looks for in the price and what it rules out first. Below, three lenses applied to the same universe on Aug 11, 2026; each left its own list, with each candidate's dossier rebuilt for that day.

Your Radarsample from Aug 11, 2026

Core lens list of Aug 11, 2026 · United States · not recalculated

Frozen sample, at least 30 days old: lists rebuilt on Sep 10, 2026 with the Radar rule in force that day, on the data of Aug 11, 2026, only for companies still covered. They are not recalculated; each company's profile does show what stands today.

Which companies should I look at first today?

It is the lens Radar opens with: it combines three criteria (quality pullback, confirmation and names that have moved between −8% and +15% over three months, with no volume spike and close to their 200-session average), reserves a minimum number of candidates for each so none takes over the list, and ranks them by priority.

Before looking, it rules out what has already risen too far over the last 60 sessions or trades at its yearly high, what comes from a very steep fall and, in the quality pullback, what fails the data-quality filter.

8 of 100 candidates that passed this lens on Aug 11, 2026. Pick one to open its dossier.

Core

Which companies should I look at first today?

House blend

8 of 100 candidates that passed this lens on Aug 11, 2026. Pick one to open its dossier.

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

Globus Medical Inc.GMED

Health Care · NYSE · price state: Repricing

Repricing in motion and Growth support. Priority 73.4 out of 100 that day.

Why it appears

  • Repricing in motion
  • Growth support
  • It enters Core through Confirmation.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · Review
  • Risk profile: Balanced.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality68
  • Profitability63
  • Growth84
  • Solvency56
  • Shareholder treatment66

Fundamentals 67 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place Globus Medical Inc. in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of Globus Medical Inc. →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

Newmont CorporationNEM

Materials · NYSE · price state: Pullback

Healthy pullback and Growth support. Priority 73.3 out of 100 that day.

Why it appears

  • Healthy pullback
  • Growth support
  • It enters Core through Quality pullback.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · Review
  • Risk profile: Compounder.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality75
  • Profitability95
  • Growth80
  • Solvency52
  • Shareholder treatment78

Fundamentals 77 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place Newmont Corporation in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of Newmont Corporation →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

Ultralife CorporationULBI

Industrials · NASDAQ · price state: Pullback

Healthy pullback and Sector relative strength turning. Priority 72.3 out of 100 that day.

Why it appears

  • Healthy pullback
  • Sector relative strength turning
  • It enters Core through Quality pullback.
  • Signals of the day: Price momentum.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · High risk
  • Risk profile: Lottery.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality49
  • Profitability35
  • Growth58
  • Solvency43
  • Shareholder treatment5

Fundamentals 42 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place Ultralife Corporation in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of Ultralife Corporation →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

Ssr Mining Inc.SSRM

Materials · NASDAQ · price state: Confirmed

Confirmed move and Growth support. Priority 72.2 out of 100 that day.

Why it appears

  • Confirmed move
  • Growth support
  • It enters Core through Confirmation.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · Review
  • Risk profile: Volatile.
  • Ex-dividend date expected on Aug 14, 2026 (3 days after the list date), unconfirmed.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality41
  • Profitability76
  • Growth76
  • Solvency72
  • Shareholder treatment5

Fundamentals 59 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place Ssr Mining Inc. in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of Ssr Mining Inc. →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

STERIS plcSTE

Health Care · NYSE · price state: Pullback

Healthy pullback and Growth support. Priority 71.6 out of 100 that day.

Why it appears

  • Healthy pullback
  • Growth support
  • It enters Core through Quality pullback.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • No open notices in its record that day.
  • Risk profile: Compounder.
  • Earnings estimated around Aug 28, 2026 (17 days after the list date); the company had not confirmed them.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality76
  • Profitability67
  • Growth71
  • Solvency65
  • Shareholder treatment59

Fundamentals 69 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place STERIS plc in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of STERIS plc →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

Hippo Holdings Inc.HIPO

Financials · NYSE · price state: Pullback

Healthy pullback and Sector relative strength turning. Priority 70.3 out of 100 that day.

Why it appears

  • Healthy pullback
  • Sector relative strength turning
  • It enters Core through Quality pullback.
  • Signals of the day: Price momentum.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · Watch
  • Risk profile: Balanced.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality11
  • Profitability56
  • Growth64
  • Solvency—
  • Shareholder treatment24

Fundamentals 40 out of 100 · 4 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place Hippo Holdings Inc. in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of Hippo Holdings Inc. →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

Cronos Group Inc.CRON

Health Care · NASDAQ · price state: Confirmed

Confirmed move and Growth support. Priority 69.7 out of 100 that day.

Why it appears

  • Confirmed move
  • Growth support
  • It enters Core through Confirmation.
  • Signals of the day: Volume surge.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · Review
  • Risk profile: Volatile.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality68
  • Profitability60
  • Growth71
  • Solvency65
  • Shareholder treatment49

Fundamentals 64 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place Cronos Group Inc. in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of Cronos Group Inc. →

Core lens list of Aug 11, 2026 · United States · not recalculated

Lens · Core

XPEL, Inc.XPEL

Consumer Discretionary · NASDAQ · price state: Repricing

Repricing in motion and Growth support. Priority 69.1 out of 100 that day.

Why it appears

  • Repricing in motion
  • Growth support
  • It enters Core through Confirmation.

What calls for caution

  • None of this lens's technical brakes fired that day: no earnings close by, not at its yearly high, no move already extended.
  • Notice · Watch
  • Risk profile: Balanced.

The next question · editorial

What would have to change in the price or in the record for it to drop off the list tomorrow?

The five fundamental pillars

  • Earnings quality32
  • Profitability75
  • Growth82
  • Solvency79
  • Shareholder treatment14

Fundamentals 60 out of 100 · 5 of 5 pillars with data that day.

What to check in the profile
  • Price and volume. Compare the range of the last sessions with the previous stretch and see whether participation changes with it.
  • Record. Open the headline notice and read the filing behind it, with its date and its source.
  • Financial statements. The five pillars come from the latest available financial statement: check its date and which pillar is missing.
  • Market context. Place XPEL, Inc. in its sector and in the market layers: what helps and what complicates the reading.
Open the public profile of XPEL, Inc. →

Has it risen over the last few sessions, with volume behind it?

It looks for a recent rise with participation: an advance over the last twenty sessions, volume above its sixty-session average and a price still below the upper part of its yearly range.

It rules out what has run too far, what rises without volume and what is already at its highs: only a recent rise counts here.

135 candidates passed this lens on Aug 11, 2026. With a free account you see how many it has each day; its list is Pro.

Is the market changing its mind about this company?

It looks for a sustained rise over the last sixty sessions, a positive last month, a price above its long average and still at a distance from the yearly high: a repricing under way, not a flash.

It rules out what moves on a one-day event and what already sits in the upper part of its yearly range.

255 candidates passed this lens on Aug 11, 2026. With a free account you see how many it has each day; its list is Pro.

A sample to explore the method. Each morning's list, Europe and your own lenses live inside the product. See plans

One morning's funnel

From the whole universe to one candidate. With the figures in sight.

From universe to candidate: how many companies we cover today, how many the Core lens selected on Aug 11, 2026, how many we show here and which one the walkthrough follows. The universe is today's; the list is from that date.

Companies covered today7,242companies in the United States and Europe
Selected by Core on Aug 11, 2026 · United States100liquidity, coverage and Core on Aug 11, 2026
Examples we show8from the frozen list
In the journey1Globus Medical Inc.

Four ways to start

The same day. Four questions.

Beyond the Core lens list, Radar highlights four candidates by role, each with its rule in plain sight. When none qualifies, the gap is stated, not filled.

  1. Review first

    The candidate with the highest priority in the lens. It is the first reading, not the best company: open its drivers and check what could change the diagnosis.

    The highest priority in the list.

    In the list of Aug 11, 2026: Globus Medical Inc. (GMED). Highest priority in the list.

  2. Best fundamentals

    An entry centred on the strength of the business, with the five pillars in front of you. It helps separate a solid fundamental reading from the appeal of the chart.

    Fundamentals of 58 out of 100 or more; among those, the highest.

    In the list of Aug 11, 2026: Newmont Corporation (NEM). Here for its fundamentals: 77/100.

  3. Already moving

    It looks for enough participation for the move to deserve attention now. When no candidate qualifies, the absence is stated together with the maximum that did occur.

    Volume of 1.5× its sixty-session average or more; among those, the largest.

    In the list of Aug 11, 2026: Cronos Group Inc. (CRON). Volume 2.23× its 60-day average.

  4. Steadiest price

    Another way into the day: the candidate with the steadiest evolution profile in the list, with its notices just as visible.

    Compounder risk profile; among those, the highest priority.

    In the list of Aug 11, 2026: STERIS plc (STE). Steady ride (compounder), priority 71.6.

How a lens is thought out

Filter before you rank. Say how old each figure is.

What Radar does before showing you anything, and what it cannot say.

The families
The recent rise, pullback, repricing, repair and confirmation lenses look for a price state, without saying which way it goes. Core is the house blend: with quotas, it brings together quality pullback, confirmation and names that have moved between −8% and +15% over three months, with no volume spike and close to their 200-session average, sorted by priority. A lens does not predict; it narrows where to look.
Your own lenses
With Pro+ you define your conditions in the Research Lab, check them against US or European history since 2005 and save them as a Radar lens, recomputed every morning alongside the built-in lenses.
Liquidity by default
The liquidity filter starts on: it prioritizes companies that pass it; you can widen the search from there. It can be switched off, and then what appears says so.
What is ruled out first
What has already risen too far in 60 sessions, what trades at its yearly high, what comes from a very steep fall and what reports earnings within days, according to each lens's rules: with earnings imminent, the price may move on the numbers rather than on what the lens looks for.
Drivers and brakes
Each candidate carries one or two drivers (the state of its price and, where present, a second item: relative strength against its sector, growth support, pullback quality or an event with a recorded date) and, where present, a technical brake. They are labels with thresholds, not opinions.
Notices, by family
Record notices come from public filings and are grouped into families (financial, liquidity, events, structure, sector, data) with their severity. The headline one is the most serious of the day; the rest is in the profile.
Coverage and bias
Operating companies in the United States and Europe. This sample is from the United States; Europe is served with the same lenses. The history used to test the lenses only includes companies still trading today: those that stopped trading are missing, in every year and not only before 2016. Data and document coverage depends on each issuer and is stated in its profile.
Honest freshness
Each list carries the date it was computed and each notice the date of its source. Old data looks old; missing data says so. We don't fill gaps.

The research continues

The candidate is the beginning. The evidence takes you further.

With Globus Medical Inc., from the Core lens, you can follow the same path as with any candidate on your list.

  1. Understand the company

    Open its profile and walk through the business, its dated accounts and the filings behind each notice.

    See Globus Medical Inc.'s profile →

    The profile shows what stands today; the list is from Aug 11, 2026.

  2. Place it in its market

    Relate the company to its sector and to the market layers: what helps and what complicates the reading.

    Explore the context →
  3. Keep the why

    Add it to Watchlist and review what changed since you added it, with a decision history. Written theses are coming soon.

    See the watchlist →

Start at your own pace

Explore first. Go deeper with access.

Public profiles, filings and guided examples are open. The full product remains in invitation-only beta.

Compare plans →
  • No account

    Each company's public profile, with its insider trades and SEC record; the available filings and the guided examples, all dated. Start whenever you like.

  • Free account

    What matters today, with its reason. In Radar, the whole of Core, in Europe and the US, with the liquidity filter and, per candidate, drivers, brakes, notice severity and risk band, and how many candidates each lens in the selector has today; in each company's profile, its insider and SEC filings as declared; today's market context; and a watchlist of up to 5 companies.

  • Pro

    Everything in the free account and, in Radar, all the built-in lenses with their list, which notice each candidate carries (its family and type), filters by notice type and «no dilution», and the cycle cohort filter. In the profile, each company's notices and their explanation and the analysis of its insiders; in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: build your own lenses, test them and bring them to Radar, which refreshes them every morning.

Does the demonstration show today's candidates?

No. These are the real lists of three lenses on Aug 11, 2026, with their dossiers rebuilt for that day. Each morning's list is inside the product.

What does Radar cover?

Operating companies in the United States and Europe. Data and document coverage depends on each issuer and is stated in its profile; the liquidity filter, on by default, prioritizes companies that pass it; you can widen the search from there.

What if a lens finds no candidates?

Absence is information too. Radar says when there is no sufficient match and, in the four roles, which maximum fell short. A list does not need filling to be useful.

The next hour,
better focused.

A short list with reasons. What calls for caution, in plain sight. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: it organizes evidence and priority. The decision is yours.

Research, not advice

HornScout is a research and analytics product. It does not provide personalized advice or trade signals. Patterns and historical context inform decisions; they do not replace your own judgment.